Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NXP Semiconductors
NXPI
CA Stock MarketDetailed Quotes
Revive Therapeutics Ltd (RVV)
- 0.025
- -0.005-16.67%
15min DelayPre-Closing Jul 15 10:38 ET
10.89MMarket Cap-0.83P/E (TTM)
0.025High0.025Low2.00KVolume0.025Open0.030Prev Close50.00Turnover0.08052wk High0.00%Turnover Ratio435.68MShares0.00552wk Low-0.03EPS TTM10.73MFloat Cap0.960Historical HighLossP/E (Static)429.35MShs Float0.005Historical Low-0.03EPS LYR0.00%Range %--Dividend TTM-2.78P/B1Lot Size--Div Yield TTM
RVV Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
RVV Orderflow
Unit: --
RVV Orderflow Trend
IntradayDayWeekMonth
No Data
Revive Therapeutics Ltd (RVV) News
Revive Therapeutics Announces Proposed Private Placement
Canadian Investment Regulatory Organization Trade Resumption - RVV
Canadian Investment Regulatory Organization Trading Halt - RVV
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
Revive Therapeutics Strengthens Bucillamine IP Portfolio With North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Express News | Revive Therapeutics: Research Study Evaluating Bucillamine Remains in Progress, Co Awaiting Final Findings
Market Insights
Hot AI Stocks Hot AI Stocks
AI stocks surge on chip demand and cloud security breakthroughs; future growth hinges on autonomous driving and global computing infrastructure AI stocks surge on chip demand and cloud security breakthroughs; future growth hinges on autonomous driving and global computing infrastructure